Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) EBITDA (2019 - 2024)

Intelligent Bio Solutions has reported EBITDA over the past 6 years, most recently at -$3.1 million for Q1 2024.

  • Quarterly results put EBITDA at -$3.1 million for Q1 2024, up 51.45% from a year ago — trailing twelve months through Mar 2024 was -$10.1 million (down 0.64% YoY), and the annual figure for FY2024 was -$10.3 million, up 1.45%.
  • EBITDA for Q1 2024 was -$3.1 million at Intelligent Bio Solutions, down from -$1.9 million in the prior quarter.
  • Over the last five years, EBITDA for INBS hit a ceiling of -$28824.0 in Q1 2020 and a floor of -$6.4 million in Q1 2023.
  • Median EBITDA over the past 5 years was -$1.9 million (2023), compared with a mean of -$2.0 million.
  • Biggest five-year swings in EBITDA: crashed 11660.49% in 2021 and later soared 98.11% in 2022.
  • Intelligent Bio Solutions' EBITDA stood at -$2.0 million in 2020, then crashed by 76.66% to -$3.5 million in 2021, then soared by 98.11% to -$65474.0 in 2022, then tumbled by 2803.82% to -$1.9 million in 2023, then plummeted by 64.19% to -$3.1 million in 2024.
  • The last three reported values for EBITDA were -$3.1 million (Q1 2024), -$1.9 million (Q4 2023), and -$2.4 million (Q3 2023) per Business Quant data.